Image For Activity Cover
TAVR and COVID-19: Latest Society Guidance and Experiences From the US and Canada Enduring
Learning Objectives
At the conclusion of the course, participants should able to:
1. Identify essential vs. non-essential procedures in TAVR
2. Perform risk stratification in patients who may need TAVR
3. Implement team-wide infection control protocols in the TAVR clinic
Faculty

Ehtisham Mahmud, MD, FACC, FSCAI

President, Society for Cardiovascular Angiography and Interventions

Edith and William Perlman Chair in Cardiology
Professor and Division Chief, Cardiovascular Medicine
Executive Director, UCSD Cardiovascular Institute-Medicine
University of California, San Diego
Chair 

David A Wood, MD, FRCPC, FACC, FSCAI
President, Canadian Association Interventional Cardiology 

Professor, University of British Columbia
Director, Centre for Cardiovascular Innovation

Director, VGH Cardiac Catheterization Laboratory

Incoming Division Head, VGH and UBC Hospital
Chair 

Kendra J. Grubb, MD, MHA, FACC

Surgical Director, Emory Structural Heart and Valve Center

Emory University
Faculty 

Kim Guibone, DNP, APRN

Structural Heart Lead Nurse Practitioner

Beth Israel Deaconess Medical Center
Faculty 

Pinak Bipin Shah, MD, FACC, FSCAI

Director of the Cardiac Catheterization Laboratory

Director of the Interventional Cardiology Training Program

Brigham and Women's Hospital in Boston
Faculty 

Molly Szerlip, MD, FACC, FSCAI

Medical Director of the Inpatient and Outpatient Valve Service Program

Program Director for the Structural Fellowship

Baylor Scott & White/The Heart Hospital
Faculty 
Agenda
  • Welcome and Introductions
  • Defining Essential vs. Non-essential Procedures in TAVR
  • How Do You Stratify Risk in TAVR Patients? 
  • Guidance to Valve Coordinators and Structural Heart Teams on Operating a TAVR Clinic in the Age of COVID-19.
  • Moderated Q&A and Panel Discussion
  • Take-Home Messages
Accreditation & Designation Statements
Accreditation Statement
The Society for Cardiovascular Angiography and Interventions is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The Society for Cardiovascular Angiography and Interventions designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

To obtain credit please complete the evaluation in its entirety.
Acknowledgment of Commercial Support
This activity is supported by unrestricted educational grants from: Edwards Lifesciences and Medtronic.

No in-kind commercial support was received.
Summary
Availability: On-Demand
Cost: FREE
Credit Offered: 1 CME Credit
Powered By